Clinical trial
Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting…
NCT00439972 · University of Washington, Other · Unknown status
Key facts
| NCT number | NCT00439972 |
|---|---|
| Title | Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity |
| Official title | Comparison of Oral and Patch Forms of Hormonal Contraception on Plasma Lipoproteins, Glycemia, Clotting Factors, Indices of Inflammation and Vascular Reactivity |
| Lead sponsor | University of Washington, Other |
| Collaborators | Ortho-McNeil Pharmaceutical Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | Ortho-Cyclen (R), Ortho Evra (R), extended use of Ortho Evra (R) |
| Enrollment | 36 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Feb 26, 2007 |
| Last update posted | Feb 14, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: